Found 28 Enz. Inhib. hit(s) with all data for entry = 50036824 
Affinity DataIC50: 180nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 360nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 390nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 890nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 1.09E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 1.10E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 1.29E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 1.36E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 1.55E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 1.66E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 2.11E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 2.15E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 2.27E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 2.27E+3nMAssay Description:TP_TRANSPORTER: inhibition of Calcein-AM efflux (Calcein-AM: 0.25 uM) in CEM/VLB100 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 2.68E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: >2.70E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: >2.73E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 2.73E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: >2.91E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 3.41E+3nMAssay Description:TP_TRANSPORTER: inhibition of Calcein-AM efflux (Calcein-AM: 0.25 uM) in CEM/VLB100 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 4.79E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 5.16E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 5.77E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 5.88E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 7.42E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: 7.55E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: >8.96E+3nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
Affinity DataIC50: >3.10E+4nMAssay Description:Human MDR1 Pgp inhibitory activity by using standard calcein-AM efflux method with the human leukemia CEM cells.More data for this Ligand-Target Pair
